Literature DB >> 16867868

The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma.

Jesús Planagumà1, Marta Gonzalez, Andreas Doll, Marta Monge, Antonio Gil-Moreno, Teresa Baró, Angel García, Jordi Xercavins, Francesc Alameda, Miguel Abal, Jaume Reventós.   

Abstract

We have recently described RUNX1/AML1 up-regulation in endometrioid endometrial carcinoma (EEC), proposing that it could play a role during the initial steps of myometrial infiltration. Some cell cycle regulators, including the cyclin-dependent kinase inhibitor p21WAF1/CIP1, have been described as targets of RUNX1/AML1. In this study, we have attempted to address the question of whether RUNX1/AML1, acting both as a gene transcription activator and a repressor, depending on the context, can be correlated with the expression of p21WAF1/CIP1 in gynecologic malignancies, in particular in EEC, where the role of p21(WAF1/CIP1) remains controversial. Toward this end, we analyzed p21WAF1/CIP1 expression in a large panel of EEC samples using real-time quantitative polymerase chain reaction and tissue microarray immunohistochemistry, and evaluated the extent to which RUNX1/AML1 and p21WAF1/CIP1 interacted in the EEC samples. The strong correlation found between RUNX1/AML1 and p21WAF1/CIP1 suggested cooperation between the 2 genes in EEC, especially in those tumor samples corresponding to stage IC carcinomas, infiltrating more than 50% of the myometrium. We hypothesize that p21WAF1/CIP1 and RUNX1/AML1 interact during the initial steps of tumor dissemination in EEC, and we discuss mechanisms that could underlie myometrial infiltration and/or the promotion of an invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867868     DOI: 10.1016/j.humpath.2006.03.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Authors:  Núria Pedrola; Laura Devis; Marta Llauradó; Irene Campoy; Elena Martinez-Garcia; Marta Garcia; Laura Muinelo-Romay; Lorena Alonso-Alconada; Miguel Abal; Francesc Alameda; Gemma Mancebo; Ramon Carreras; Josep Castellví; Sílvia Cabrera; Antonio Gil-Moreno; Xavier Matias-Guiu; Juan L Iovanna; Eva Colas; Jaume Reventós; Anna Ruiz
Journal:  Clin Exp Metastasis       Date:  2015-04-30       Impact factor: 5.150

2.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

Review 3.  New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Authors:  Cornelia Johanna Franziska Scheitz; Tudorita Tumbar
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

4.  Deregulation of RAD21 and RUNX1 expression in endometrial cancer.

Authors:  Anna Supernat; Sylwia Lapińska-Szumczyk; Sambor Sawicki; Dariusz Wydra; Wojciech Biernat; Anna J Zaczek
Journal:  Oncol Lett       Date:  2012-07-09       Impact factor: 2.967

5.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

Authors:  I Masse; L Barbollat-Boutrand; M Molina; O Berthier-Vergnes; N Joly-Tonetti; M T Martin; C Caron de Fromentel; J Kanitakis; J Lamartine
Journal:  Cell Death Dis       Date:  2012-06-07       Impact factor: 8.469

Review 6.  RUNX1 Dosage in Development and Cancer.

Authors:  Michael Lie-A-Ling; Renaud Mevel; Rahima Patel; Karen Blyth; Esther Baena; Valerie Kouskoff; Georges Lacaud
Journal:  Mol Cells       Date:  2020-02-29       Impact factor: 4.250

Review 7.  Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer.

Authors:  Jianfa Wu; Li Zhang; Suqin Wu; Zhou Liu
Journal:  Front Mol Biosci       Date:  2022-07-01

8.  miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.

Authors:  Jian Ma; Da Li; Fan-Fei Kong; Di Yang; Hui Yang; Xiao-Xin Ma
Journal:  J Exp Clin Cancer Res       Date:  2018-02-01

9.  Transcription of the Human 5-Hydroxytryptamine Receptor 2B (HTR2B) Gene Is under the Regulatory Influence of the Transcription Factors NFI and RUNX1 in Human Uveal Melanoma.

Authors:  Manel Benhassine; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2018-10-21       Impact factor: 5.923

10.  RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.

Authors:  Renaud Mevel; Ivana Steiner; Susan Mason; Laura Ca Galbraith; Rahima Patel; Muhammad Zh Fadlullah; Imran Ahmad; Hing Y Leung; Pedro Oliveira; Karen Blyth; Esther Baena; Georges Lacaud
Journal:  Elife       Date:  2020-10-07       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.